2 Small Cap Biotechs to Bet On
Merrimack and Threshold Pharmaceuticals will soon announce catalysts to propel their stocks, says Rob Goldman of Goldman Small Cap Research.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
